| NCT05335356 | Biocon Biologics UK Ltd | Moderate to Severe Chronic Plaque Psoriasis | 2022-06-28 | PHASE3 |
| NCT04785326 | Dong-A ST Co., Ltd.|Meiji Seika Pharma Co., Ltd. | Moderate to Severe Chronic Plaque Psoriasis | 2021-04-28 | PHASE3 |
| NCT04744363 | Alvotech Swiss AG|IQVIA Pty Ltd | Psoriasis | 2021-05-25 | PHASE1 |
| NCT04428814 | Celltrion | Healthy Subjects | 2020-08-03 | PHASE1 |
| NCT02199496 | National Institute of Allergy and Infectious Diseases (NIAID) | Gastrointestinal Inflammation Associated With CVID|CVID Enteropathy | 2015-10-19 | PHASE1|PHASE2 |
| NCT05890118 | RANI Therapeutics | Healthy Volunteers | 2023-08-30 | PHASE1 |
| NCT04673786 | Celltrion | Psoriasis | 2021-01-11 | PHASE3 |
| NCT03651518 | Assistance Publique - H?pitaux de Paris|URC-CIC Paris Descartes Necker Cochin | Inflammatory Disease|Autoimmune Diseases | 2020-10-20 | PHASE2 |
| NCT05861167 | Sixth Affiliated Hospital, Sun Yat-sen University | Crohn Disease | 2023-06-01 | PHASE4 |
| NCT00723528 | Janssen Pharmaceutical K.K. | Psoriasis | 2008-03 | PHASE3 |
| NCT02054481 | Boehringer Ingelheim | Psoriasis | 2014-02 | PHASE2 |
| NCT01081730 | Janssen Biotech, Inc. | Psoriasis | 2010-02-09 | |
| NCT00307437 | Centocor Research & Development, Inc. | Psoriasis | 2005-05 | PHASE3 |
| NCT01708629 | Bausch Health Americas, Inc. | Plaque Psoriasis | 2012-09 | PHASE3 |
| NCT06935929 | Second Affiliated Hospital of Wenzhou Medical University | Crohn Disease | 2020-01-01 | |
| NCT00265122 | Centocor, Inc. | Crohn Disease | 2004-04 | PHASE2 |
| NCT06742606 | Ain Shams University | Effect of Drug | 2025-01-15 | EARLY_PHASE1 |
| NCT04089345 | Universitaire Ziekenhuizen KU Leuven|Janssen Pharmaceuticals | Pouchitis | 2020-06-15 | PHASE3 |
| NCT03466411 | Janssen Research & Development, LLC | Crohn´s Disease | 2018-04-13 | PHASE2|PHASE3 |
| NCT03942120 | Janssen Korea, Ltd., Korea | Crohn Disease | 2019-04-08 | |
| NCT04882072 | Janssen Pharmaceutical K.K. | Takayasu Arteritis | 2021-09-15 | PHASE3 |
| NCT04607980 | Amgen | Plaque Psoriasis | 2020-11-11 | PHASE3 |
| NCT04816513 | Janssen Research & Development, LLC | Healthy | 2021-04-14 | PHASE1 |
| NCT01706692 | Swiss Dermatology Network for Targeted Therapies | Psoriasis | 2011-02 | |
| NCT02407236 | Janssen Research & Development, LLC | Colitis, Ulcerative|Inflammatory Bowel Diseases | 2015-07-10 | PHASE3 |
| NCT01558310 | Paul Steven Yamauchi, MD, PhD|Janssen Services, LLC | Scalp Psoriasis|Plaque Psoriasis | 2012-08 | PHASE4 |
| NCT03148860 | Dr. Frank Behrens|Janssen-Cilag Ltd. | Psoriatic Arthritis | 2016-12-15 | PHASE3 |
| NCT01645280 | Janssen Research & Development, LLC | Arthritis, Rheumatoid | 2012-08 | PHASE2 |
| NCT02319759 | Janssen Research & Development, LLC | Psoriatic Arthritis | 2015-03-27 | PHASE2 |
| NCT04060888 | Janssen Research & Development, LLC | Lupus Erythematosus, Systemic | 2020-07-14 | PHASE3 |
| NCT04093531 | University of Rochester|Janssen, LP | Primary Sj?gren Syndrome | 2020-01-15 | PHASE1 |
| NCT05083182 | Janssen Research & Development, LLC | Arthritis, Juvenile | 2022-08-30 | PHASE3 |
| NCT06786507 | Helwan University | Ulcerative Colitis (UC) | 2025-05-15 | |
| NCT03941132 | University of British Columbia|Juvenile Diabetes Research Foundation|Janssen, LP | Type 1 Diabetes Mellitus | 2021-01-04 | PHASE2|PHASE3 |
| NCT05252533 | Janssen Research & Development, LLC | Juvenile Psoriatic Arthritis|Psoriasis|Arthritis, Juvenile | 2022-05-24 | PHASE1 |
| NCT06912815 | Xiang Gao | Crohn Disease (CD) | 2024-08-01 | NA |
| NCT04595409 | Bioeq GmbH | Plaque Psoriasis | 2020-11-09 | PHASE3 |
| NCT01081704 | Centocor, Inc. | Healthy | 2009-10 | PHASE1 |
| NCT02648581 | Assistance Publique - H?pitaux de Paris|URC-CIC Paris Descartes Necker Cochin | Beh?et Disease | 2017-06-14 | PHASE2 |
| NCT01369329 | Janssen Research & Development, LLC | Crohn´s Disease|IBD|Colitis|Inflammatory Bowel Disease | 2011-07 | PHASE3 |
| NCT01812954 | Jochen Schmitt.|Merck Sharp & Dohme LLC | Psoriasis | 2013-03 | |
| NCT04996485 | National Medical Research Center for Children´s Health, Russian Federation | Congenital Ichthyosis | 2021-03-01 | PHASE4 |
| NCT01369355 | Janssen Research & Development, LLC | Crohn´s Disease|Colitis|IBD|Inflammatory Bowel Disease | 2011-09-13 | PHASE3 |
| NCT02684357 | AbbVie|Boehringer Ingelheim | Psoriasis | 2016-03 | PHASE3 |
| NCT02561806 | Eli Lilly and Company | Plaque Psoriasis | 2015-10 | PHASE3 |
| NCT04978493 | Boehringer Ingelheim | Crohn Disease | 2021-12-02 | PHASE2 |
| NCT03107793 | Janssen-Cilag Ltd. | Crohn Disease | 2017-04-19 | PHASE3 |
| NCT04655807 | Janssen Research & Development, LLC | Crohn Disease | 2021-03-03 | PHASE2 |
| NCT03881059 | Bristol-Myers Squibb | Active Psoriatic Arthritis | 2019-04-01 | PHASE2 |
| NCT07116967 | Bristol-Myers Squibb | Plaque Psoriasis | 2025-09-22 | PHASE3 |
| NCT01059773 | Janssen-Cilag International NV | Psoriasis | 2009-10 | PHASE4 |
| NCT05092269 | Janssen Research & Development, LLC | Crohn Disease|Colitis, Ulcerative|Arthritis, Psoriatic | 2021-10-18 | PHASE3 |
| NCT01704534 | University Medical Center Groningen|Janssen-Cilag B.V. | Hidradenitis Suppurativa | 2012-05 | PHASE2 |
| NCT06934226 | Janssen Research & Development, LLC | Plaque Psoriasis | 2025-04-15 | PHASE3 |
| NCT02826603 | Novartis Pharmaceuticals | Plaque Psoriasis | 2016-06-22 | PHASE3 |
| NCT04372108 | Janssen Scientific Affairs, LLC | Crohn Disease|Colitis, Ulcerative | 2021-06-24 | |
| NCT04245215 | Belgian Inflammatory Bowel Disease Research and Development (BIRD) VZW|Janssen Cilag N.V.+S.A. | Crohn Disease | 2020-03-11 | PHASE3 |
| NCT05928039 | University of Calgary|Alimentiv Inc. | Crohn Disease | 2023-10-25 | PHASE4 |
| NCT04117932 | CHU de Reims | Bullous Pemphigoid | 2020-03-11 | PHASE2 |
| NCT02349061 | Janssen Research & Development, LLC | Lupus Erythematosus, Systemic | 2015-10-15 | PHASE2 |
| NCT03981744 | Janssen Pharmaceutical K.K. | Polymyositis|Dermatomyositis | 2019-07-26 | PHASE3 |
| NCT04779762 | Wolfson Medical Center|Sheba Medical Center | Crohn Disease | 2022-01 | NA |
| NCT03782376 | Janssen-Cilag Ltd. | Crohn Disease | 2018-12-20 | PHASE3 |
| NCT03370133 | UCB Biopharma SRL | Chronic Plaque Psoriasis|Moderate to Severe Chronic Plaque Psoriasis|Psoriatic Arthritis | 2017-12-06 | PHASE3 |
| NCT06249555 | Alimentiv Inc.|Takeda | Crohn´s Disease | 2024-03-20 | |
| NCT02698475 | Janssen Research & Development, LLC | Psoriasis | 2016-05 | PHASE3 |
| NCT02786732 | MedDerm Associates | Psoriasis | 2012-08 | PHASE3 |
| NCT01999868 | National Institute of Allergy and Infectious Diseases (NIAID)|Immune Tolerance Network (ITN) | Psoriasis | 2014-03-19 | PHASE2 |
| NCT06425549 | UCB Biopharma SRL | Moderate to Severe Plaque Psoriasis | 2024-06-25 | PHASE3 |
| NCT03167437 | National Institute of Allergy and Infectious Diseases (NIAID) | Crohn´s Disease | 2017-10-30 | PHASE1|PHASE2 |
| NCT05530122 | Tampere University Hospital | Ulcerative Colitis | 2009-01 | |
| NCT07444060 | Second Affiliated Hospital, School of Medicine, Zhejiang University|People´s Hospital of Chongqing | CD - Crohn´s Disease|Stricture; Bowel|IBD - Inflammatory Bowel Disease | 2026-03-01 | |
| NCT06807593 | M.D. Anderson Cancer Center|Janssen Research & Development, LLC | Cancer | 2026-02-24 | PHASE2 |
| NCT04967508 | Samsung Bioepis Co., Ltd. | Psoriasis|Moderate to Severe Plaque Psoriasis | 2021-07-06 | PHASE3 |
| NCT04963725 | Janssen Pharmaceutical K.K. | Ulcerative Colitis | 2021-07-18 | |
| NCT04572815 | Fred Hutchinson Cancer Center | Hematologic and Lymphocytic Disorder|Hematopoietic and Lymphoid System Neoplasm | 2021-05-14 | PHASE2 |
| NCT01008995 | Centocor, Inc. | Psoriasis | 2009-10 | PHASE3 |
| NCT04673357 | Janssen Research & Development, LLC | Crohn Disease | 2021-04-06 | PHASE3 |
| NCT02144857 | University of Athens | Psoriasis | 2014-05-30 | PHASE4 |
| NCT03606499 | Janssen Cilag S.A.S. | Crohn Disease|Colitis, Ulcerative | 2018-09-26 | |
| NCT01945086 | Janssen Pharmaceutical K.K. | Dermatitis, Atopic | 2013-09 | PHASE2 |
| NCT00267969 | Centocor Research & Development, Inc. | Psoriasis | 2005-12 | PHASE3 |
| NCT07352566 | University of California, San Francisco | Psoriasis|Atopic Dermatitis | 2026-01-01 | PHASE4 |
| NCT07576452 | University Hospital, Clermont-Ferrand|Groupe d´Etude Therapeutique des Affections Inflammatoires Digestives | Ulcerative Colitis (UC) | 2026-06-01 | PHASE4 |
| NCT04629196 | NYU Langone Health | Crohn Disease | 2022-02-16 | PHASE4 |
| NCT01077362 | Janssen Research & Development, LLC | Arthritis, Psoriatic | 2010-03 | PHASE3 |
| NCT07263464 | Second Affiliated Hospital of Wenzhou Medical University | Inflammatory Bowel Disease (Crohn´s Disease and Ulcerative Colitis)|Polymorphism, Single Nucleotide|Ustekinumab | 2018-01-01 | |
| NCT02156375 | Janssen Research & Development, LLC | Healthy | 2014-05 | PHASE1 |
| NCT07268534 | Assistance Publique - H?pitaux de Paris | Folliculitis Decalvans (FD) | 2026-04-01 | PHASE2 |
| NCT05386290 | Peking Union Medical College Hospital | Ulcerative Colitis|Crohn Disease | 2020-07-09 | |
| NCT03351647 | Hospices Civils de Lyon | Crohn Disease | 2018-02-14 | |
| NCT02407223 | Janssen Research & Development, LLC | Nonradiographic Axial Spondylitis, Ankylosing | 2015-07-13 | PHASE3 |
| NCT05270733 | University Hospitals Cleveland Medical Center|LEO Foundation|Case Western Reserve University | Psoriasis | 2022-11-10 | PHASE4 |
| NCT05029921 | Janssen Research & Development, LLC | Crohn Disease | 2021-12-10 | PHASE4 |
| NCT00320216 | Centocor, Inc. | Psoriasis | 2003-11 | PHASE2 |
| NCT03336281 | Janssen Cilag S.A.S. | Psoriatic Arthritis | 2017-04-25 | |
| NCT04630028 | Janssen Research & Development, LLC | Colitis, Ulcerative | 2021-03-17 | PHASE3 |
| NCT05702879 | Insel Gruppe AG, University Hospital Bern|Bristol-Myers Squibb | Ulcerative Colitis | 2023-09-06 | |
| NCT07303686 | McGill University Health Centre+Research Institute of the McGill University Health Centre|Janssen Inc. | Crohn Disease (CD)|Ulcerative Colitis (UC) | 2025-10-08 | PHASE4 |
| NCT02968108 | Janssen Research & Development, LLC | Crohn Disease | 2017-01-18 | PHASE1 |
| NCT01389973 | Janssen Research & Development, LLC | Primary Biliary Cirrhosis | 2011-09 | PHASE2 |
| NCT01806662 | Rockefeller University | Atopic Dermatitis | 2013-03 | PHASE2 |
| NCT01369342 | Janssen Research & Development, LLC | Crohn´s Disease|Inflammatory Bowel Disease|IBD|Colitis | 2011-07 | PHASE3 |
| NCT03366142 | National Institute of Allergy and Infectious Diseases (NIAID) | LAD1 | 2018-07-02 | PHASE1|PHASE2 |
| NCT03464136 | Janssen Scientific Affairs, LLC | Crohn Disease | 2018-03-29 | PHASE3 |
| NCT02330380 | University Hospitals Cleveland Medical Center|National Psoriasis Foundation | Psoriasis|Inflammation | 2013-04 | |
| NCT03712826 | Hospices Civils de Lyon | Crohn Disease | 2022-07-24 | NA |
| NCT04772274 | Samsung Bioepis Co., Ltd. | Healthy | 2021-02-04 | PHASE1 |
| NCT05186623 | Asan Medical Center | Ulcerative Colitis | 2022-02-05 | |
| NCT07177118 | First Affiliated Hospital of Wenzhou Medical University|Taizhou Hospital|Second Affiliated Hospital of Wenzhou Medical University | Crohn Disease|Crohn Disease and Ulcerative Colitis | 2025-10-20 | PHASE3 |
| NCT05242458 | Janssen Research & Development, LLC|ImproveCareNow (ICN)|Children´s Hospital Medical Center, Cincinnati | Crohn´s Disease | 2022-03-21 | |
| NCT04496063 | Groupe d´Etude Therapeutique des Affections Inflammatoires Digestives|Janssen, LP | Crohn´s Disease | 2020-11-16 | PHASE4 |
| NCT07138898 | NYU Langone Health | Rheumatic Disease | 2025-09 | PHASE2 |
| NCT03043677 | Fundación de Investigación Biomédica - Hospital Universitario de La Princesa | Inflammatory Bowel Disease | 2016-04-01 | |
| NCT02763969 | Bristol-Myers Squibb | Psoriasis | 2016-05-18 | PHASE1 |
| NCT02693470 | Chang Gung Memorial Hospital | Psoriasis With Cell-derived Microparticles | 2014-08 | PHASE4 |
| NCT06082986 | Xian-Janssen Pharmaceutical Ltd. | Crohn Disease | 2023-10-09 | |
| NCT05725876 | University Medical Center Groningen | Psoriasis|Crohn Disease | 2025-01-06 | PHASE1 |
| NCT02877134 | Janssen Research & Development, LLC | Crohn Disease | 2016-08-25 | PHASE2 |
| NCT02438787 | Janssen Research & Development, LLC | Axial Spondyloarthritis | 2015-07-31 | PHASE3 |
| NCT01647152 | National Eye Institute (NEI) | Uveitis | 2012-07-03 | PHASE1|PHASE2 |
| NCT04524611 | AbbVie | Crohn´s Disease (CD) | 2020-09-30 | PHASE3 |
| NCT00747344 | Centocor, Inc. | Psoriasis | 2008-12 | PHASE3 |
| NCT03362736 | Janssen Research & Development, LLC | Crohn Disease | | |
| NCT06453317 | Medical University of Lodz|Poznan University of Medical Sciences|Clinical Hospital Heliodor Swiecicki of the Medical University of Karol Marcinkowski in Pozna?|Norbert Barlicki Memorial Teaching Hospital No. 1 of the Medical University of Lodz|Medical Research Agency, Poland | Ulcerative Colitis|Inflammatory Bowel Diseases | 2025-02-17 | PHASE2 |
| NCT00955279 | Centocor, Inc. | Sarcoidosis | 2009-11 | PHASE2 |
| NCT03218488 | Janssen-Cilag International NV | Psoriasis | 2017-10-25 | |
| NCT03885713 | Fundación de Investigación Biomédica - Hospital Universitario de La Princesa | Inflammatory Bowel Diseases|Crohn Disease|Ulcerative Colitis | 2019-09-10 | PHASE4 |
| NCT06691061 | Humanitas Clinical and Research Center | Ulcerative Colitis (Disorder) | 2023-08-01 | |
| NCT02955147 | Massachusetts General Hospital | Giant Cell Arteritis|Temporal Arteritis|Horton´s Disease | 2016-12-01 | PHASE1|PHASE2 |
| NCT06520397 | Sixth Affiliated Hospital, Sun Yat-sen University | Crohn Disease | 2024-07-15 | PHASE4 |
| NCT02204397 | Jewish General Hospital | Type 1 Diabetes Mellitus | 2015-11 | PHASE2 |
| NCT06935942 | Second Affiliated Hospital of Wenzhou Medical University | Crohn Disease | 2020-01-01 | |
| NCT01009086 | Janssen Research & Development, LLC | Arthritis, Psoriatic | 2009-12 | PHASE3 |
| NCT03847272 | Centre Hospitalier Universitaire Dijon | Patients With Newly Diagnosed Active NISU | 2019-08-01 | PHASE2 |
| NCT04632927 | Novartis Pharmaceuticals | Psoriatic Arthritis | 2020-12-21 | PHASE3 |
| NCT01090427 | Janssen Research & Development, LLC | Psoriasis | 2010-05 | PHASE3 |
| NCT06997055 | Celltrion HealthCare France|Sanoia | Crohn Disease|Plaque Psoriasis | 2025-03-17 | |
| NCT02117765 | University of British Columbia|Juvenile Diabetes Research Foundation | Type 1 Diabetes | 2015-03 | PHASE1|PHASE2 |
| NCT05387031 | Second Affiliated Hospital, School of Medicine, Zhejiang University|Sixth Affiliated Hospital, Sun Yat-sen University|Second Affiliated Hospital of Soochow University|Chongqing Renji Hospital, University of Chinese Academy of Sciences|The First Affiliated Hospital of Zhejiang Chinese Medical University|Seventh Medical Center of PLA Army General Hospital|First People´s Hospital of Hangzhou|Yangzhou University|Xian-Janssen Pharmaceutical Ltd. | Crohn Disease|Stricture; Bowel|Intestinal Stricture | 2024-08-01 | |
| NCT02684370 | AbbVie|Boehringer Ingelheim | Psoriasis | 2016-02 | PHASE3 |
| NCT03517722 | Janssen Research & Development, LLC | Lupus Erythematosus, Systemic | 2018-04-16 | PHASE3 |
| NCT05535738 | Wei-Che Ko | Skin Inflammation|Allergic Contact Dermatitis | 2022-11-15 | PHASE2|PHASE3 |
| NCT05896943 | Evangelismos Hospital | Ulcerative Colitis | 2022-04-01 | |
| NCT01330901 | Charite University, Berlin, Germany | Ankylosing Spondylitis | 2011-10 | PHASE2 |
| NCT02835716 | Millennium Magnetic Technologies, LLC | Alzheimer Disease | 2016-09 | |
| NCT04610476 | University of Erlangen-Nürnberg Medical School | Psoriatic Arthritis|Withdrawal|Reduction | 2020-10-19 | PHASE3 |
| NCT01550744 | Janssen Biotech, Inc. | Psoriasis | 2012-03 | PHASE3 |
| NCT01276847 | Merck Sharp & Dohme LLC | Psoriasis | 2011-03 | PHASE1 |
| NCT03711448 | Centre Hospitalier Universitaire Dijon | Patients Relapsing Refractory Giant Cell Arteritis | 2019-01-07 | PHASE2 |
| NCT01091051 | Innovaderm Research Inc.|Janssen-Ortho LLC | Palmo-Plantar Pustular Psoriasis|Palmo-Plantar Pustulosis | 2010-03 | PHASE3 |
| NCT05728008 | IRCCS San Raffaele | Ulcerative Colitis | 2022-04-05 | |
| NCT02103361 | University of California, San Diego|The Organization of Teratology Information Specialists|Janssen Biotech, Inc. | Psoriasis|Pregnancy|Psoriatic Arthritis|Crohn Disease | 2013-11 | |
| NCT02187172 | University of Pennsylvania|Janssen Scientific Affairs, LLC | Psoriasis|Cardiovascular Disease | 2014-07 | PHASE4 |
| NCT07529236 | Centre Hospitalier Universitaire de Nice | Chronic Inflammatory Bowel Diseases | 2026-04-19 | |
| NCT04549792 | Northwestern University|Janssen Scientific Affairs, LLC | Ichthyosis | 2021-04-01 | EARLY_PHASE1 |
| NCT02437162 | Janssen Research & Development, LLC | Axial Spondyloarthritis | 2015-09-03 | PHASE3 |
| NCT04761627 | Amgen | Psoriasis | 2021-03-24 | PHASE3 |
| NCT06788340 | Odense University Hospital | Inflammatory Bowel Diseases|Crohn Disease|Ulcerative Colitis | 2025-09-01 | PHASE4 |
| NCT01713400 | H. Lee Moffitt Cancer Center and Research Institute|Gateway for Cancer Research | Graft vs. Host Disease | 2013-02-25 | PHASE2 |
| NCT07495644 | Assiut University | Inflamatory Bowel Disease (Crohn's and Ulcerative Colitis) | 2026-03-01 | |
| NCT04030533 | Janssen Research & Development, LLC | Healthy | 2019-11-29 | PHASE1 |
| NCT04435600 | AbbVie | Psoriasis | 2020-07-14 | PHASE3 |
| NCT07149467 | Sixth Affiliated Hospital, Sun Yat-sen University | Crohn's Disease Aggravated|Crohn's Disease in Remission | 2025-09-10 | PHASE3 |
| NCT02203032 | Janssen Research & Development, LLC | Psoriasis | 2014-10-07 | PHASE3 |
| NCT01511315 | University of California, San Francisco | Psoriasis | 2012-03 | PHASE4 |
| NCT04305327 | LEO Pharma | Psoriasis | 2022-12-07 | PHASE3 |
| NCT03629379 | Universitaire Ziekenhuizen KU Leuven | Inflammatory Bowel Diseases|Psoriasis | 2019-01-22 | PHASE4 |
| NCT05705856 | Second Affiliated Hospital, School of Medicine, Zhejiang University | Crohn Disease | 2023-02-15 | |
| NCT02911116 | National Eye Institute (NEI) | Uveitis | 2017-03-30 | PHASE2 |
| NCT07057856 | Second Affiliated Hospital of Wenzhou Medical University | Crohn´s Disease | 2018-01-01 | |
| NCT06045754 | Takeda | Crohn´s Disease | 2024-04-18 | PHASE4 |
| NCT05299931 | Belgian Inflammatory Bowel Disease Research and Development (BIRD) VZW|Janssen Cilag N.V.+S.A. | Crohn Disease | 2021-09-10 | PHASE3 |
| NCT03926130 | Eli Lilly and Company | Crohn´s Disease | 2019-07-23 | PHASE3 |
| NCT00771667 | Centocor, Inc. | Crohn´s Disease | 2008-12 | PHASE2 |
| NCT01090063 | Tufts Medical Center|Centocor, Inc. | Moderate to Severe Palmar Plantar Psoriasis | 2010-02 | NA |
| NCT02074982 | Novartis Pharmaceuticals | Chronic Plaque Type Psoriasis | 2014-02-26 | PHASE3 |
| NCT03358706 | Janssen Research & Development, LLC | Crohn Disease|Ulcerative Colitis | 2018-02-02 | PHASE1 |
| NCT01708603 | Bausch Health Americas, Inc. | Moderate to Severe Plaque Psoriasis | 2012-08 | PHASE3 |
| NCT03495973 | Janssen-Cilag Ltd. | Crohn Disease | 2017-10-25 | |